ArticleBreast cancer research and treatment2025

Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.

Rohan Chaubal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.